EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease
paradigm_report_works_22122023
10.3233_jpd-191841
34
2
2020
543
558
article
10
cc-by-nc
https://escholarship.org/uc/item/1vs1b0ct
Journal of Parkinson's Disease
SAGE Publications
Caroline M. Tanner
Rajesh Pahwa
Robert A. Hauser
Wolfgang H. Oertel
Stuart Isaacson
Joseph Jankovic
Reed Johnson
Dustin Chernick
Jean Hubble
True
10.3233/jpd-191841
EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our
Terms of Service and Privacy Policy.